<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

NEW UPDATE: How the Trump Tax Bill will Impact You:

Learn More

Value Series IV: Using P/B Ratio Creates a Solid Investment Foundation for Abbott Laboratories Employees

image-table

For Abbott Laboratories employees, understanding and using basic valuation metrics like the Price-to-Book ratio can help you make better decisions and position your portfolio for the long haul - especially during volatile markets,  '  says Kevin Landis, of the Retirement Group, a division of Wealth Enhancement Group.

As a Abbott Laboratories employee or a retired person, data-driven investment strategies like those of great investors can set your portfolio up for growth despite market volatility,  '  says Paul Bergeron, of The Retirement Group, a division of Wealth Enhancement Group.

In this article we will discuss:

1. Important valuation metrics for investors include Price-to-Book and Price-to-Earnings ratios.

2. Value investing strategies versus glamour investing strategies.

3. Equal-weighted portfolios and Kelly Weighting to Maximize Long Term growth.

High volatility in the markets today means it seems like the right time to review key value metrics from our four-part series. We know that as a Abbott Laboratories employee or retiree with little market analysis experience, the valuation process can be confusing. But we are here to tell you that valuation need not be complicated to be successful. Simple valuation techniques like the price-to-book ratio are generally easy to apply and have worked well when done so correctly. And sometimes investors want their clients to beat the market.

You are one of those investors - check out this strategy from investment greats. Some value investors have beaten the average annualized returns of the S&P 500 historically - and many have decades of track record proving it. Abbott Laboratories employees should know the tactics of Warren Buffett, Benjamin Graham, David Dodd, Charlie Munger, Christopher Browne and Seth Klarman. Their investment style focuses on four metrics of a value investment.

These are the Price to Earnings Ratio, Price to Cash Flow Ratio, High Dividend Yield and Price to Book Ratio. These metrics are clear indicators of an undervalued security. Once overvalued security was returned to fair value then we would see positive returns on that security. Those metrics can help you position yourself in the market for higher returns for Abbott Laboratories employees. We will examine the effect of investing based on some characteristics and how their investment returns are correlated. Today, I close out the four-part TRG value Series with the absolute king of metrics, the Price-to-Book Value ratio (P/B) - book value is preferred by many Value investors to cash flow and earnings metrics because Book Value is more stable year over year versus cash flow and earnings which can vary greatly.

Such a property is important to watch for those at Abbott Laboratories who understand that while a business at a cyclical trough with lower cash flow or price-to-earnings might look expensive on price-to-cash flow or price-to-earnings the same business may look cheap on price-to-book value. This is because book value will not drop much or at all in a downturn - and vice versa. Thus, price-to-book value provides a more reliable picture of a company's normal business performance that Abbott Laboratories employees can use to improve their investment decisions and investment performance, the argument goes. Benjamin Graham popularized the indicator in his books Security Analysis and the Intelligent Investor.

Nobel Prize winning Eugene Fama and research partner Kenneth French used the ratio to describe stock returns in their three-and five-factor models. Professor Joseph Piotroski employs the ratio as the only valuation measure in his F-Score methodology. We understand how data-driven research matters to Abbott Laboratories employees and retirees. The results of two Fama and French backtests of the book value-to-market equity (inverse of the PB ratio) data set from 1926 to 2013 are shown below. By December 2013, the sample had 3,175 firms (Carlisle-PB, P2).

Value decile had the 459 stocks with the highest earnings yield and glamour decile had the 404 stocks with the lowest earnings yield. Those glamour stocks average USD 7.48 billion and the value stocks USD 2.54 billion - that average is skewed by the biggest companies. For context the 3,175th company has a market capitalization of USD 404 million today (less than average, but still investable for most investors). Portfolios are formed June 30 and rebalanced annually. When accounting for this backtest, Abbott Laboratories employees may remember that two portfolios are weighted by market capitalization - that is, bigger firms contribute more to the portfolio performance and smaller firms contribute less.

Figure 1 shows that the value decile has outperformed the glamour decile by 12.6 percent compounded (17.7 percent in the average year) over the full period compared with 8.6 percent for the glamour decile (10.9 percent in the average year) (Carlisle-PB, P3). These are far below the returns on the price-to-earnings and cash-flow ratios mentioned earlier. But despite the irregularity, Abbott Laboratories employees need to know that earnings and cash flow backtests went back to only 1951 and book value return data goes back to 1926. The difference is due to the 1929 crash, which inflated returns. The effect of the crash is obvious; the value decile took twenty years to recover.

Abbott Laboratories employees should also note that the glamour decile hasn't grown since 2000. To make a comparison possible of the performance of the book value with that of earnings and cash flow over the same period I also measured returns starting in 1951. Since 1951, the low P/B value decile has produced a compound annual growth rate of 15.0 percent and an average annual return of 17.9 percent. The glamour decile delivered a 9.6 percent CAGR and an AAR of 12.6 percent over the same period (Carlisle-PB, P5). Such returns approximate those of the low P / CF and P / E studies over the same period. In their study, the quintile of the lowest P / E stocks outperformed the high P / E quintile.

Its portfolio with the lowest P / E stock returned 11.61% annualized versus 4.83% for the highest P / E portfolio and 7.55% for the used universe of stocks. This graph shows how the cumulative returns fare (not even close). Abbott Laboratories employees can use this information to avoid investing in underperforming assets and to identify economic trends driving higher ROI. They mean absolutely nothing unless you're running an index or hugging an index. The simplest portfolio weighting scheme is to equally weight each position (and If we're willing to take a little more volatility for a little more return, we can also Kelly weight our best ideas). The Kelly Weighting is determined by the Kelly Criterion - a formula for determining what percentage of capital should be invested in each trade to maximize long-term growth.

The two components of the formula (Kelly% = W-[(1 - W) / R]) are the winning probability (W) and the win / loss ratio (R). The win/loss ratio is the sum of the positive trade amounts minus the negative trading amounts. Its result will tell investors how much of their total capital to invest. Through Kelly Weighting, employed or retired investors from Abbott Laboratories can understand their exposure to each asset in their portfolio and make better asset allocation decisions. Abbott Laboratories employees should also include equal weight return statistics for book value. On average, the value generated 20.2 percent compounded return (27.3 percent on average) over glamour's 6.3 percent compounded return (10.4 percent on average) in the equal weight backtest (Carlisle-PB, P10).

From 1951 onwards the equally weighted P/B value decile has generated a compound annual growth rate (CAGR) of 20.0 percent and an average annual return (AAR) of 25.4 percent (Carlisle-PB, P11). The glamour decile returned a CAGR of 6.4 percent and an AAR of 10.8 percent over the same period. Those returns approximate those of the low P / CF and P / E studies during the same period. With this information in mind, Abbott Laboratories employees have to understand that the value portfolios delivered better book value per dollar invested versus the glamour portfolios (4.57x average versus 0.25x in the glamour portfolios) (Carlisle-PB, P12). Value outperformed glamour since 1999 by 15.9 percent compounded and 16.1 percent in the average year in the equal-weight portfolios (Carlisle-PB, P13).

We know how data-driven solutions are for our Abbott Laboratories employees and retirees so here is another study on P/CF ratio. Exhibit 6 below shows global all-cap results across three price metrics in a Brandes Research Institute study. They confirmed a consistent premium across all metrics. Focus is on P/CF ratio and outperformance in decile 10 value stocks. The smallest outperformance between decile 1 glamour stocks and decile 10 value stocks was observed with P/B measurement, where the average outperformance was 7.1% (Brandes, p. A nationwide Group of financial advisors known as The Retirement Group.

We only plan for and design retirement portfolios for transitioning corporate employees. And each representative of The Group has been handpicked by The Retirement Group in select cities throughout the United States. Each advisor was screened for pension expertise, financial planning experience and portfolio construction knowledge. TRG believes in teamwork to find solutions to our clients' problems. A conservative investment philosophy guides the team in constructing client portfolios with laddered bonds / CDs / mutual funds / ETFs / Annuities / Stocks and other investments.

They handle Retirement / Pensions / Tax / Asset Allocation / Estate / Elder Care issues. This document uses different research tools and techniques. All attempts to estimate future results involve assumptions and judgments and are therefore only tentative estimates. The law, investment climate, interest rates and personal circumstances will all change and will affect how accurate our estimations are and how appropriate our recommendations are. Such a plan requires ongoing change sensitivities as well as constant re-examination and alteration of the plan.

So update your plan a few months before your expected retirement date and do an annual review. Nothing contained herein shall be construed as an attempt by The Retirement Group, LLC or any of its employees to practice law or accounting. We look forward to speaking with any tax and/or legal professionals you may select regarding the implications of our recommendations. Through your retirement years we will continue to update you on issues affecting your retirement via our complimentary and proprietary newsletters, workshops & periodic updates. Or call us at (800) 900-5867.

Articles you may find interesting:

Loading...

Sources:

1. Investopedia. 'Using the Price-To-Book (P/B) Ratio to Evaluate Companies.'   Investopedia , 7 Mar. 2018,  https://www.investopedia.com/investing/using-price-to-book-ratio-evaluate-companies/?utm_source=chatgpt.com .

2. Investopedia. 'Warren Buffett's 90/10 Strategy: A Simple Guide for Investors.'   Investopedia , 18 Dec. 2015,  https://www.investopedia.com/articles/personal-finance/121815/buffetts-9010-asset-allocation-sound.asp?utm_source=chatgpt.com .

3. Investopedia. 'Price-to-Book (P/B) Ratio: Meaning, Formula, and Example.'   Investopedia , 21 Mar. 2003,  https://www.investopedia.com/terms/p/price-to-bookratio.asp?utm_source=chatgpt.com .

4. Dadisfire.com. 'Warren Buffett's Wisdom on Frugality and Financial Freedom.'   Dadisfire.com , 5 Feb. 2025,  https://dadisfire.com/warren-buffett-financial-wisdom/?utm_source=chatgpt.com .

5. Yingyushijie.com. 'The Winning Investment Strategies of Bogle, Buffett, Graham, and Others.'   Yingyushijie.com , 18 Jan. 2025,  https://yingyushijie.com/business/detail/id/7735/category/46.html?utm_source=chatgpt.com

How does the Abbott Laboratories Annuity Retirement Plan (ARP) determine the eligibility requirements for employees, and how can potential changes in federal regulations impact these requirements? Employees of Abbott Laboratories may need to understand the nuances of eligibility, particularly regarding age and service criteria. Changes in laws governing retirement benefits could pose questions about continued eligibility and could affect when employees can begin pension payments.

Eligibility Requirements & Impact of Federal Regulations: Employees at Abbott Laboratories become eligible for the ARP by being part of a participating division, being at least 21 years old, and residing in the U.S. (with certain exceptions for U.S. employees abroad). Changes in federal regulations could potentially alter these eligibility criteria, especially since such rules often influence age and service requirements for retirement plans. Any changes in legislation regarding retirement benefits might necessitate adjustments in eligibility rules, affecting when employees can begin receiving pension payments.

Can you explain the significance of Vesting Service in the context of the Abbott Laboratories Annuity Retirement Plan? Employees often wonder how their years of service influence their benefit eligibility and the amount they can expect. Understanding the elements that constitute Vesting Service, and the implications of terminating employment before achieving vesting, is crucial for Abbott Laboratories employees planning for retirement.

Significance of Vesting Service: Vesting Service at Abbott Laboratories refers to the time an employee must accumulate to gain entitlement to pension benefits, irrespective of continued employment. This service is critical as it determines the security of an employee's future benefits and the degree of an employee's investment in the company's pension plan. Employees who terminate employment prior to achieving full vesting lose entitlement to accrued pension benefits, making understanding and accruing Vesting Service essential for long-term financial planning.

In what ways does the calculation of Final Average Pay play a role in determining retirement benefits under the Abbott Laboratories Annuity Retirement Plan? The methodology used to calculate an employee's Final Average Pay can significantly impact the retirement income they receive. Employees at Abbott Laboratories should consider how their earnings history and the inclusion or exclusion of certain payments factor into their anticipated benefits.

Role of Final Average Pay in Benefit Calculation: Final Average Pay (FAP) is crucial in determining the pension benefits under the ARP as it represents the average of an employee’s highest earnings over a specified period. Abbott’s ARP calculates pension based on a percentage of the FAP, multiplied by years of eligible service. This calculation means that higher earnings towards the end of an employee's career can significantly increase the pension benefits, incentivizing employees to maximize their earnings potential in their final working years.

What optional forms of payment are available to employees upon retirement under the Abbott Laboratories Annuity Retirement Plan, and how do these choices affect overall pension benefits? Abbott Laboratories employees need to evaluate whether to choose single or joint survivor annuities, among other options, as these decisions can have long-term financial implications for both themselves and their beneficiaries.

Optional Forms of Payment at Retirement: The ARP offers various payment options upon retirement, including single and joint survivor annuities, which affect the benefit's distribution and longevity. These choices impact financial planning for retirement, particularly in ensuring that a spouse or beneficiary may continue to receive benefits after the retiree's death. The selection between these options should align with personal financial needs and considerations for dependents' security.

Different employees may have varying perspectives on the importance of early retirement options offered by Abbott Laboratories. What are the qualifications for early special retirement, and how does this option affect retirement income? Employees contemplating retirement before the standard age should understand how factors such as age, years of service, and the specific provisions of the Abbott Laboratories Annuity Retirement Plan influence their benefits.

Early Retirement Qualifications and Impacts: Early retirement under the ARP is available to employees who meet specific age and service criteria, allowing them to retire with reduced benefits before reaching the normal retirement age. This option can significantly affect retirement income, depending on the number of years ahead of normal retirement age the employee chooses to retire, making it crucial for employees to understand the financial trade-offs involved in retiring early.

How does the Abbott Laboratories Annuity Retirement Plan ensure compliance with the Employee Retirement Income Security Act (ERISA), and what rights do employees have under this act? Abbott Laboratories employees should be informed about their rights regarding plan documentation, required disclosures, and recourse in the event of disputes pertaining to their retirement benefits.

ARP Compliance with ERISA: The ARP is designed to comply with the Employee Retirement Income Security Act (ERISA), providing employees with rights to information about plan features and funding, benefits accrual, and recourse in case of disputes. Compliance with ERISA ensures that employees' retirement benefits are protected under federal law, offering a framework for security and transparency in their retirement planning.

How do Abbott Laboratories employees who experience a medical leave of absence or disability maintain their retirement service credits under the Annuity Retirement Plan? Understanding the interaction between long-term disability benefits, medical leave, and retirement plan participation is essential for employees navigating health-related issues while planning for their retirement.

Impact of Medical Leave or Disability on Retirement Credits: Employees on medical leave or disability continue to accrue service credits under the ARP, ensuring that such periods do not adversely affect their pension benefits. This protection helps employees who are temporarily unable to work due to health issues maintain their trajectory towards earning full retirement benefits.

Given the potential for changes to the Abbott Laboratories Annuity Retirement Plan, how can employees stay informed about their rights and any modifications to the plan’s terms? Employees at Abbott Laboratories should have access to reliable communication channels, including how to receive updates about the retirement plan, which could impact their financial planning.

Staying Informed About Plan Changes: Employees can stay informed about changes to the ARP through regular communications from Abbott Laboratories, access to updated plan documents, and direct inquiries to the Abbott Benefits Center. Staying proactive in seeking information and understanding the implications of plan modifications is essential for effective retirement planning.

What processes should Abbott Laboratories employees follow if they wish to obtain a statement regarding their entitlement to a pension? Employees looking to plan for retirement need clear instructions on how to request this crucial information and understand its importance in their long-term financial strategy.

Obtaining a Pension Statement: Employees wishing to obtain a statement of their pension entitlements under the ARP should contact the Abbott Benefits Center. Clear instructions on how to request this information are crucial for employees to plan accurately for retirement and understand their accrued benefits.

If an employee at Abbott Laboratories has further questions about the Annuity Retirement Plan or requires clarification on the document contents, how can they effectively contact the appropriate department? Knowing how to reach out to Abbott Laboratories' Benefits Center regarding retirement plan inquiries is vital for all employees wanting to confirm their understanding or seek additional information about their retirement benefits.

Contacting the Appropriate Department for Plan Inquiries: For further inquiries or clarification regarding the ARP, employees should contact the Abbott Benefits Center. Knowing the correct contact information and how to reach out effectively is vital for resolving concerns and gaining a deeper understanding of their retirement benefits.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Abbott Laboratories offers an Employee Stock Purchase Plan (ESPP) that allows employees to purchase company stock at a discounted price through automatic payroll deductions. This plan operates in two periods: an "offering period" where payroll deductions accumulate, and a "purchase period" where those deductions are used to buy Abbott/AbbVie stock. The ESPP is a qualified plan, meaning contributions are made on a pre-tax basis, allowing for tax-deferred growth. Employees can benefit from lower taxes on gains if they hold the stock for at least one year and sell it at least two years after the offering date. This plan helps employees benefit from the company's performance while also providing tax savings. 401(k) Plan - Stock Retirement Plan (SRP) Abbott's 401(k) plan, known as the Stock Retirement Plan (SRP), provides a significant company match. Employees who contribute 2% of their gross pay receive a 5% company match. In 2022, employees can contribute up to $20,500 annually ($27,000 if over age 50), with employer and employee contributions capped at a combined $61,000 ($67,500 if over 50). Contributions are automatically deducted from paychecks, deferring taxes until retirement when the employee might be in a lower tax bracket. Additionally, Abbott’s Freedom 2 Save program automatically contributes up to 5% of an employee’s gross salary to the SRP plan if the employee contributes at least 2% of their income to student loan repayment. This generous matching scheme and additional programs can help employees build substantial retirement savings over time. [Source: Abbott Benefits Guide, 2022, p. 10]
Abbott Laboratories has announced significant layoffs in 2024, including the closure of its Fairfield plant, which will result in nearly 200 job losses due to cost-cutting measures. This comes amidst a broader trend of job cuts in their medtech and diagnostic divisions, particularly as demand for COVID-19 tests diminishes. Additionally, Abbott is cutting 3,000 jobs globally as part of a restructuring effort to streamline operations and improve efficiencies. This news is critical for stakeholders to understand the economic and political pressures influencing these decisions, including rising inflation, shifts in demand for healthcare products, and strategic moves to maintain financial stability in a volatile market​ (Hoodline)​​ (MedTech Dive)​​ (FierceBiotech)​​ (FiercePharma)​​ (Press Herald)​.
Abbott Laboratories offers stock options and RSUs to align employee interests with company goals. Stock options are granted with a predetermined price and vesting period, while RSUs vest over a few years based on performance or tenure. In 2022, Abbott enhanced its equity programs, emphasizing performance-based RSUs. The trend continued in 2023 and 2024, with broader RSU availability and performance-linked stock options. Executives and middle management are the primary recipients, fostering long-term alignment with company performance. [Source: Abbott Annual Reports 2022-2024, p. 34] Abbott’s RSU program provides employees with shares of company stock subject to a vesting schedule based on performance milestones or years of service. Once vested, RSUs convert to stock, and their fair market value is taxed as ordinary income. Proper tax planning around RSUs is crucial to minimize tax liability, as vesting can significantly impact income and tax brackets. Employees need to decide whether to hold or sell the stock after it becomes available, considering that selling within one year of conversion results in higher tax rates compared to long-term capital gains rates for stock held for more than a year. Integrating RSUs into a comprehensive wealth management plan is essential for maximizing their benefits.
New call-to-action

Additional Articles

Check Out Articles for Abbott Laboratories employees

Loading...

For more information you can reach the plan administrator for Abbott Laboratories at 1295 state street Springfield, MA 1111; or by calling them at 1-866-329-6277.

https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/EmpHandbook.pdf - Page 12,https://abbottbenefits.com/wp-content/uploads/BenefitsHighlightsGuide_2024.pdf - Page 7,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/RetirementGuide2023.pdf - Page 22,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/HealthcareOptions2024.pdf - Page 19,https://abbottbenefits.com/wp-content/uploads/2023/01/BenefitsHighlightsGuide_2023.pdf - Page 14,https://abbottbenefits.com/wp-content/uploads/2022/05/BenefitsHighlightsGuide_2022.pdf - Page 8,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/AbbottAnnuityRetirementPlan.pdf - Page 11,https://cache.hacontent.com/ybr/R516/00472_ybr_ybrfndt/downloads/AbbottAbbVieMEPP.pdf - Page 25,https://abbottbenefits.com/wp-content/uploads/2024/02/BenefitsCenterGuide.pdf - Page 16,https://www.abbott.com/content/dam/abbott/en-us/documents/pdfs/annual-report-2023.pdf - Page 55

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Abbott Laboratories employees